The president’s Middle East visit produced multibillion-dollar technology investments by the Saudis and Emiratis. But they ...

Lars Fruergaard Jørgensen, the chief executive of once-highflying Danish drug manufacturer Novo Nordisk, is stepping down after eight years in the role, the maker of the drugs Ozempic and Wegovy ...